News

From Digital Health to Drug Discovery: Cancer Projects Funded in RAP Spring 2026 Cycle

Nine investigators and teams were awarded grants in support of cancer research projects in the spring 2026 cycle of the UCSF Resource Allocation Program (RAP). Funded by various agencies across UCSF, the awards span a range of topics from digital health and drug discovery to imaging, survivorship

Shaping Our AI Future

As AI continues to reshape medicine and biomedical research, the Cancer Center is taking a thoughtful approach to its potential—and its limitations. Below, Julian Hong, MD, the Cancer Center’s new head of AI, discusses the role AI can play in improving patient care, accelerating discovery, and

For Early Prostate Cancer ‘Active Surveillance’ Is Now #1 Choice

Three decades after UC San Francisco pioneered “active surveillance” for patients with low-risk prostate cancer, a new study has found that the vast majority of veterans with the diagnosis pursued this option instead of treatment. In 2024, 93% of veterans with low-risk prostate cancer — so called

Can Mini Organs Help Predict Breast Tumors’ Response to Therapy?

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from an innovative clinical trial called I-SPY and rapid experimentation on lab-grown mini tumors. The advance could hasten more personalized

UCSF Health Earns 30th Consecutive US News Best Hospitals Honor Roll

UCSF Health-UCSF Medical Center has been named to the U.S. News & World Report Best Hospitals Honor Roll for adult care for the 30th consecutive year, reflecting excellence across a broad range of specialties, procedures, and conditions. UCSF Medical Center remained tied as the highest-ranked

Multidisciplinary Expert Team Makes the Difference for Rare Cervical Chordoma

Zachary Davis had been dealing with neck and shoulder pain on and off for several years, managing with over-the-counter medications as needed. But one day in February, a roller coaster ride at an amusement park near his home in Los Angeles sent him reeling. “At the very first turn, it snapped my

UCSF Cancer Researcher Awarded Prize for Early Career Scientists

UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute (CRI), a New York-based nonprofit that funds and promotes cancer immunotherapy research. The IGNITE Award — Inspiring Growth and Nurturing Independence Through Excellence — is a new